ss-2 adrenergic receptor (AR): Another immune checkpoint (IC)" A phase II clinical trial of propranolol (P) with pembrolizumab (Pem) in patients with unresectable stage III and stage IV melanoma
Proceedings article published in 2022 by
Benjamin Switzer,
Manu R. Pandey,
Alexandra Valentine,
Agnieszka Witkiewicz,
Erik Knudsen,
Kristopher Attwood,
Joseph Tario,
Pauline Funchain 
,
Joseph J. Drabick,
Hemn Mohammadpour,
Marc S. Ernstoff,
Igor Puzanov,
Elizabeth A. Repasky,
Shipra Gandhi
,
Joseph J. Drabick,
Hemn Mohammadpour,
Marc S. Ernstoff,
Igor Puzanov,
Elizabeth A. Repasky,
Shipra Gandhi
